PL3348273T3 - Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowych - Google Patents
Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowychInfo
- Publication number
- PL3348273T3 PL3348273T3 PL18157960T PL18157960T PL3348273T3 PL 3348273 T3 PL3348273 T3 PL 3348273T3 PL 18157960 T PL18157960 T PL 18157960T PL 18157960 T PL18157960 T PL 18157960T PL 3348273 T3 PL3348273 T3 PL 3348273T3
- Authority
- PL
- Poland
- Prior art keywords
- xyloglucan
- proteins
- treatment
- compositions based
- intestinal disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/732—Pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/733—Fructosans, e.g. inulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/80—Polymers containing hetero atoms not provided for in groups A61K31/755 - A61K31/795
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20140705 | 2014-04-15 | ||
PCT/EP2015/058162 WO2015158771A1 (en) | 2014-04-15 | 2015-04-15 | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders |
EP18157960.8A EP3348273B8 (en) | 2014-04-15 | 2015-04-15 | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders |
EP15719637.9A EP3131568B1 (en) | 2014-04-15 | 2015-04-15 | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3348273T3 true PL3348273T3 (pl) | 2020-03-31 |
Family
ID=50897780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL18157960T PL3348273T3 (pl) | 2014-04-15 | 2015-04-15 | Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowych |
Country Status (6)
Country | Link |
---|---|
US (3) | US20170027980A1 (pl) |
EP (2) | EP3131568B1 (pl) |
CA (1) | CA2945631C (pl) |
ES (2) | ES2750152T3 (pl) |
PL (1) | PL3348273T3 (pl) |
WO (1) | WO2015158771A1 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3131568B1 (en) * | 2014-04-15 | 2018-06-06 | Novintethical Pharma SA | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders |
US10780146B2 (en) | 2016-05-31 | 2020-09-22 | Devintec Sagl | Compositions for the treatment of intestinal disorders |
CN109689067A (zh) * | 2016-07-13 | 2019-04-26 | 卡莱多生物科技有限公司 | 聚糖组合物和使用方法 |
IT201800006400A1 (it) * | 2018-06-18 | 2019-12-18 | Composizione per le patologie gastriche ed esofagee | |
GR1009632B (el) * | 2018-07-09 | 2019-10-25 | Ιουλια Κλεωνος Τσετη | Διατροφικο συμπληρωμα για την απο του στοματος χορηγηση συνδυασμου λακτοφερινης, ξυλογλυκανης, προανθοκυανιδινων και σιμεθικονης, χρησιμων για την προληψη λοιμωξεων του γαστρεντερικου και ουροποιητικου συστηματος |
EP3846784A1 (en) | 2018-09-06 | 2021-07-14 | Fachhochschule Nordwestschweiz | Controlled drug release formulation |
IT201900025246A1 (it) * | 2019-12-23 | 2021-06-23 | Devintec Sagl | Composizioni topiche comprendenti proteine vegetali e polifenoli |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3515667A (en) * | 1966-12-12 | 1970-06-02 | Universal Oil Prod Co | Drilling fluid additive |
US4070488A (en) * | 1975-11-25 | 1978-01-24 | Davis Rachel D | Nutritive composition |
JPS5939363B2 (ja) * | 1978-02-24 | 1984-09-22 | 克彦 谷 | 食塩製造方法 |
US4783446A (en) * | 1985-11-22 | 1988-11-08 | Neushul Mariculture Incorporated | Method for the treatment of AIDS virus and other retroviruses |
US5262315A (en) * | 1990-04-19 | 1993-11-16 | Pernod Ricard | Production of vanillin by bioconversion of benzenoid precursors by pyenoporus |
US5444054A (en) * | 1994-04-01 | 1995-08-22 | Abbott Labatories | Method of treating ulcerative colitis |
IT1283911B1 (it) | 1996-02-05 | 1998-05-07 | Farmigea Spa | Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo |
US6203797B1 (en) * | 1998-01-06 | 2001-03-20 | Stephen C. Perry | Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome |
US6387210B1 (en) * | 1998-09-30 | 2002-05-14 | Kimberly-Clark Worldwide, Inc. | Method of making sanitary paper product from coarse fibers |
NZ523050A (en) * | 2000-05-12 | 2004-11-26 | Bengt Krister Olson | Combined marine and plant extract compositions |
US6811243B2 (en) * | 2001-10-05 | 2004-11-02 | E. I. Du Pont De Nemours And Company | Priming fluid for ink jet printheads |
CA2554140A1 (en) * | 2004-01-30 | 2005-08-18 | Mars, Incorporated | Methods and compositions for treating cancer |
ITBO20050388A1 (it) | 2005-06-06 | 2006-12-07 | Alfa Wassermann Spa | Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche |
EP1764105A1 (de) | 2005-09-20 | 2007-03-21 | Rentschler Arzneimittel GmbH | Verwendung von Gerbstoffen zur Behandlung der Chemotherapie induzierten Diarrhoe |
EP1974735A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Reduction of risk of diarrhoea |
AU2008273699A1 (en) * | 2007-07-06 | 2009-01-15 | Lupin Limited | Pharmaceutical compositions of rifaximin |
US20090062191A1 (en) | 2007-08-29 | 2009-03-05 | Kiel Laboratories, Inc. | Composition for maintaining gastrointestinal homeostasis |
ITRM20070510A1 (it) | 2007-10-02 | 2009-04-03 | Rmfa Trading S A | Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico. |
EP2361623A1 (en) | 2010-02-09 | 2011-08-31 | Novintethical Pharma, SAGL | Composition comprising a polyphenol salt and corresponding use |
CA2800382C (en) | 2010-05-24 | 2019-09-17 | Indena S.P.A. | Tamarind seed polysaccharide for use in the treatment of microbial infections |
CN103025387B (zh) | 2010-05-24 | 2016-06-01 | 因德纳有限公司 | 用于治疗炎性疾病的罗望子种子多糖 |
ITMI20110934A1 (it) | 2011-05-24 | 2012-11-25 | Cohen Miguel Angel Alonso | Tannato di gelatina e sue associazioni per uso nel trattamento di malattie infiammatorie gastrointestinali |
ITMI20121328A1 (it) * | 2012-07-30 | 2014-01-31 | Probiotical Spa | Composizione per dispositivo medico comprendente ceppi di batteri produttori di esopolisaccaridi in associazione con gomme e/o gelatine. |
EP3131568B1 (en) * | 2014-04-15 | 2018-06-06 | Novintethical Pharma SA | Compositions based on xyloglucan and proteins for the treatment of intestinal disorders |
-
2015
- 2015-04-15 EP EP15719637.9A patent/EP3131568B1/en active Active
- 2015-04-15 ES ES18157960T patent/ES2750152T3/es active Active
- 2015-04-15 CA CA2945631A patent/CA2945631C/en active Active
- 2015-04-15 EP EP18157960.8A patent/EP3348273B8/en active Active
- 2015-04-15 PL PL18157960T patent/PL3348273T3/pl unknown
- 2015-04-15 WO PCT/EP2015/058162 patent/WO2015158771A1/en active Application Filing
- 2015-04-15 ES ES15719637.9T patent/ES2675305T3/es active Active
- 2015-04-15 US US15/303,753 patent/US20170027980A1/en not_active Abandoned
-
2017
- 2017-05-17 US US15/597,664 patent/US10064886B2/en active Active
-
2018
- 2018-07-17 US US16/036,966 patent/US10758561B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2945631C (en) | 2023-04-11 |
US20180318333A1 (en) | 2018-11-08 |
EP3348273B8 (en) | 2019-09-18 |
EP3131568A1 (en) | 2017-02-22 |
US20170027980A1 (en) | 2017-02-02 |
US20170252366A1 (en) | 2017-09-07 |
US10758561B2 (en) | 2020-09-01 |
EP3348273B1 (en) | 2019-07-31 |
ES2750152T3 (es) | 2020-03-25 |
ES2675305T3 (es) | 2018-07-10 |
EP3131568B1 (en) | 2018-06-06 |
CA2945631A1 (en) | 2015-10-22 |
WO2015158771A1 (en) | 2015-10-22 |
US10064886B2 (en) | 2018-09-04 |
EP3348273A1 (en) | 2018-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201901279B (en) | Compositions and methods for treatment of neurological disorders | |
IL255109A0 (en) | New dihydropyridoisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders | |
IL260352B (en) | Methods and preparations for the treatment of neurological disease | |
EP3183005A4 (en) | Methods and compositions for the treatment of metabolic disorders | |
GB201402070D0 (en) | Pharmaceutical compositions for the treatment of inflammatory disorders | |
EP3104706A4 (en) | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease | |
HK1256721A1 (zh) | 用於治療眼部病症的化合物和組合物 | |
EP3182989A4 (en) | Methods and compositions for the prevention and treatment of disease | |
IL266047A (en) | Methods and preparations for the treatment of Fabry disease | |
GB201411241D0 (en) | Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
PL3348273T3 (pl) | Kompozycje na bazie ksyloglukanu i białek do leczenia zaburzeń jelitowych | |
HUE049518T2 (hu) | Készítmények és eljárások a szem megbetegedéseinek kezelésére és diagnosztizálására | |
GB201401086D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders | |
HK1231386A1 (zh) | 免疫疾病的治療 | |
SG11201708181RA (en) | Methods for the treatment of inflammatory disorders | |
EP3258930A4 (en) | Oxabicycloheptanes and oxabicycloheptenes for the treatment of depressive and stress disorders | |
IL251736B (en) | Methods and compositions for the treatment of radiation-related disorders | |
EP3341006A4 (en) | COMPOSITIONS AND METHODS FOR TREATING NERVE DAMAGE | |
GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
EP3107534A4 (en) | Compositions and methods for the treatment of neurodegenerative diseases | |
EP3096775A4 (en) | Socs mimetics for the treatment of diseases | |
IL282455A (en) | Methods and preparations for the treatment of secretory disorders | |
EP3328428A4 (en) | METHOD AND COMPOSITIONS FOR TREATING IMMUNOMODULATIVE ILLNESSES AND DISORDERS | |
SG11201706369PA (en) | Compositions and methods for the treatment of mucositis | |
IL254140A0 (en) | Preparations and combinations for use in the treatment of angiogenic diseases and disorders |